M
Michael R. McNeil
Researcher at Colorado State University
Publications - 213
Citations - 19022
Michael R. McNeil is an academic researcher from Colorado State University. The author has contributed to research in topics: Mycobacterium smegmatis & Mycobacterium tuberculosis. The author has an hindex of 73, co-authored 213 publications receiving 18159 citations. Previous affiliations of Michael R. McNeil include University of St Andrews & University of Georgia.
Papers
More filters
Book ChapterDOI
Isolation and characterization of plant cell walls and cell wall components
TL;DR: The methods used for isolating and characterizing the noncellulosic polysaccharides of the primary walls of suspension-cultured sycamore cells are described, which are applicable to the study of other types of cell walls.
Journal ArticleDOI
Structure and function of the primary cell walls of plants.
TL;DR: All glycosyl residues (except the residue at the reducing end of an oligosaccharide, which is called a glycose residue) are glycosidically linked at C-l and this fact is assumed in the notation used, and, thus, C-\ is not mentioned.
Journal ArticleDOI
Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
TL;DR: Using signature-tagged mutagenesis, three attenuated M. tuberculosis mutants are isolated that cannot synthesize or transport a complex, cell wall-associated lipid called phthiocerol dimycocerosate (PDIM) which is found only in pathogenic mycobacteria.
Journal ArticleDOI
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.
Helena I. Boshoff,Timothy G. Myers,Brent R. Copp,Michael R. McNeil,Michael A Wilson,Clifton E. Barry +5 more
TL;DR: The transcriptional profile generated by a crude marine natural product recapitulated the mechanistic prediction from the pure active component of Mycobacterium tuberculosis and provide a rational basis for the selection of critical metabolic targets for screening for new agents with improved activity against this important human pathogen.
Journal ArticleDOI
An unambiguous nomenclature for xyloglucan‐derived oligosaccharides
Stephen C. Fry,William S. York,Peter Albersheim,Alan G. Darvill,Hayashi Takahisa,Jean-Paul Joseleau,Yoji Kato,Ester P. Lorences,Gordon Maclachlan,Michael R. McNeil,Andrew J. Mort,J. S. Grant Reid,Hanns Ulrich Seitz,Robert R. Selvendran,Alphons G. J. Voragen,Alan R. White +15 more
TL;DR: A revised system of abbreviated names is proposed for xyloglucan-derived oligosaccharides, where each (1→4)-linked β-D-glucosyl residue (and the reducing terminal n- glucose moiety) of the backbone is given a one-letter code according to its substituents.